Serimmune (@serimmune) 's Twitter Profile
Serimmune

@serimmune

Immune intelligence company

ID: 1173702742528815105

linkhttp://www.serimmune.com calendar_today16-09-2019 20:59:09

468 Tweet

435 Followers

313 Following

Serimmune (@serimmune) 's Twitter Profile Photo

Identifying antibody biomarkers is essential for the detection, stratification, & prognosis of conditions like #autoimmunedisease or #cancer. Uncover how our #SERA technology can be applied to test them via @BioCompare: biocompare.com/Future-Lab/599… #immuneprofiling

Identifying antibody biomarkers is essential for the detection, stratification, & prognosis of conditions like #autoimmunedisease or #cancer. Uncover how our #SERA technology can be applied to test them via @BioCompare: biocompare.com/Future-Lab/599…  

#immuneprofiling
Serimmune (@serimmune) 's Twitter Profile Photo

#TeamSerimmune takes on #SITC2023 in San Diego, 11/1-5. Engage with us at Booth 334 to discover how #SERA can support your research & initiatives. Event info: sitcancer.org/2023/home #immuneprofiling #immunoassay #cancerresearch

#TeamSerimmune takes on #SITC2023 in San Diego, 11/1-5. Engage with us at Booth 334 to discover how #SERA can support your research & initiatives.  

Event info: sitcancer.org/2023/home  

#immuneprofiling #immunoassay #cancerresearch
Serimmune (@serimmune) 's Twitter Profile Photo

Who’s ready for #SITC2023? We’re here in San Diego this week at Booth 334. Stop by to discover how #SERA can support your research and initiatives. Can’t join us? Reach out to our team of experts: serimmune.com/contact/ #immuneprofiling #immunoassay #cancerresearch

Who’s ready for #SITC2023? We’re here in San Diego this week at Booth 334. Stop by to discover how #SERA can support your research and initiatives. Can’t join us? Reach out to our team of experts: serimmune.com/contact/    

#immuneprofiling #immunoassay #cancerresearch
Serimmune (@serimmune) 's Twitter Profile Photo

#TeamSerimmune is ready for #VaccineSummit 2023! Our CTO John Shon will present on the #SERA platform on 11/14. Meet our team at our booth to learn more about our technology and how it can aid in vaccine development. We look forward to an exciting week! scientiameetings.com/conferences/va…

#TeamSerimmune is ready for #VaccineSummit 2023! Our CTO John Shon will present on the #SERA platform on 11/14. Meet our team at our booth to learn more about our technology and how it can aid in vaccine development. We look forward to an exciting week! 

scientiameetings.com/conferences/va…
Serimmune (@serimmune) 's Twitter Profile Photo

#SITC2023 was informative, exciting & inspiring! We enjoyed connecting with colleagues to learn about the latest in #immunotherapy for cancer. Couldn’t connect with us at the event, but want to know more about #SERA? Chat with our team: serimmune.com/contact/ #immuneprofiling

Serimmune (@serimmune) 's Twitter Profile Photo

Who: CTO John Shon What: “SERA: Universal serology enabling high-throughput, antigen agnostic studies of adaptive immune responses” When: 11/14, 3:20pm Where: #VaccineSummit 2023 Check it out & stop by our booth!

Who: CTO John Shon 

What: “SERA: Universal serology enabling high-throughput, antigen agnostic studies of adaptive immune responses” 

When: 11/14, 3:20pm 

Where: #VaccineSummit 2023  

Check it out & stop by our booth!
Serimmune (@serimmune) 's Twitter Profile Photo

What makes our #SERA platform unique? Uncover how it can be applied to test a variety of biomarkers for some of immunology’s most researched diseases. Via @BioCompare: biocompare.com/Future-Lab/599… #immuneprofiling #autoimmunedisease #cancerresearch

Serimmune (@serimmune) 's Twitter Profile Photo

What a fantastic time at #VaccineSummit! We enjoyed CTO John Shon’s presentation & making some great connections at our booth. Missed us? Shoot us a message to learn more about #SERA here: serimmune.com/contact/ #vaccines #VaccineResearch #VaccineTechnology

Serimmune (@serimmune) 's Twitter Profile Photo

What makes our #SERA platform unique? Uncover how it can be applied to test a variety of biomarkers for some of immunology’s most researched diseases. Via Biocompare: biocompare.com/Future-Lab/599… #immuneprofiling #autoimmunedisease #cancerresearch

What makes our #SERA platform unique? Uncover how it can be applied to test a variety of biomarkers for some of immunology’s most researched diseases.  

Via Biocompare: biocompare.com/Future-Lab/599…  

#immuneprofiling #autoimmunedisease #cancerresearch
Serimmune (@serimmune) 's Twitter Profile Photo

#WorldVaccineWest was the place to be! Check out photos from our Senior Director, Business Development Inger Larsen as she joined industry colleagues at this industry event. Looking forward to an exciting 2024! #SERA #immuneprofiling #immunoassay

#WorldVaccineWest was the place to be! Check out photos from our Senior Director, Business Development Inger Larsen as she joined industry colleagues at this industry event. Looking forward to an exciting 2024!  

#SERA #immuneprofiling #immunoassay
Serimmune (@serimmune) 's Twitter Profile Photo

Our CTO John Shon was featured on mendelspod with host @TheralDTimpson. They spoke about the latest applications of our #SERA technology and how it can impact the future of precision immunology: mendelspod.com/p/mapping-the-… #podcast #immunology #immunity #antibodies

Serimmune (@serimmune) 's Twitter Profile Photo

Our Serum Epitope Repertoire Analysis (SERA) platform is a 10 billion bacterial display peptide array that functions as a universal serology assay." Explore how our #SERA platform can maximize #research in the latest @Biocompare piece on multiplex assays: biocompare.com/Editorial-Arti…

Serimmune (@serimmune) 's Twitter Profile Photo

We’re wrapping up an exciting year at Serimmune! Highlight #1: having our #SERA platform used in a breakthrough #LongCOVID study from Dr. Akiko Iwasaki & team in nature: nature.com/articles/s4158… We look forward to other research advancements in 2024! #immuneprofiling

Serimmune (@serimmune) 's Twitter Profile Photo

Another great highlight of 2023 was having our CTO John Shon interview with Biocompare in November to walk through #immunoassays and their applications with other industry experts. Check it out: biocompare.com/Editorial-Arti… #immunology

Serimmune (@serimmune) 's Twitter Profile Photo

Wishing you a safe, happy holiday season from all of us at #TeamSerimmune! We hope you take time to rest and recharge with your families as we charge up for an exciting year.

Wishing you a safe, happy holiday season from all of us at #TeamSerimmune! We hope you take time to rest and recharge with your families as we charge up for an exciting year.
Serimmune (@serimmune) 's Twitter Profile Photo

Happy New Year from #TeamSerimmune! We look forward to another packed year as we strive to bring innovations to research with our #SERA platform.

Happy New Year from #TeamSerimmune! We look forward to another packed year as we strive to bring innovations to research with our #SERA platform.
Serimmune (@serimmune) 's Twitter Profile Photo

Excited to share this paper with Moderna using our SERA assay to study the antibody immune response to mRNA COVID-19 vaccines #antibody #vaccines frontiersin.org/journals/immun…

Serimmune (@serimmune) 's Twitter Profile Photo

Attending World Vaccine Congress this week? Be sure to stop by our booth 630 and learn about how our SERA platform is being used to assess vaccines #WVCDC #WVC2024 terrapinn.com/conference/wor…

Serimmune (@serimmune) 's Twitter Profile Photo

In case you missed it check out this news release about our recent publication from Moderna utilizing our SERA platform to study the antibody response to mRNA-1273 vaccine and boosters #COVID_19 #mRNA #moderna apnews.com/press-release/…

Serimmune (@serimmune) 's Twitter Profile Photo

Attending AACR 2024? Be sure to stop by our poster presentation on the development of a B-cell epitope classifier for early detection of renal cell carcinoma 4/7 from 1:30-5PM abstractsonline.com/pp8/#!/20272/p… #aacr24 #biomarkers #antibody #oncology